Poster # 1015 Selection Of Proper Candidates With Resected IIIA-N2 Non-small-cell Lung Cancer For Postoperative Radiotherapy: A New Prediction Model

Presenter: Zhouguang Hui, MD

About the Presenter:
CURRICULUM VITAE Name: Zhouguang Hui Address: Cancer Institute & Hospital Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) P. O. Box 2258, Beijing 100021 P. R. China Tel: +86-10-87787639 (O) Fax: +86-10-67706153 (O) E-mail: drhuizg@163.com Position: Associate Professor Department of Radiation Oncology Cancer Institute & Hospital, CAMS & PUMC, P. R. China. Educations M.D. Faculty of Medicine, Shanghai Medical University, P.R. China, 1997. Ph.D. Radiation Oncology, Peking Union Medical College (PUMC) & Chinese Academy of Medical Sciences (CAMS). P.R. China, 2003. Postdoctoral Experiences 2006-2007 Baylor College of Medicine, USA. 2005-2006 Louisiana State University Health Sciences Center£¬USA. Professional Activities/Major National Appointments 2008-Present Associate Professor Department of Radiation Oncology, Cancer Institute & Hospital, CAMS & PUMC, P. R. China. 2003-2008 Attending Physician Department of Radiation Oncology, Cancer Institute & Hospital, CAMS & PUMC, P. R. China. 1997-2003 Resident Physician Department of Radiation Oncology, Cancer Institute & Hospital, CAMS & PUMC, P. R. China. Language Chinese & English Awards and Honors 1. The Science and Technology Nova of Beijing City£¬Beijing Municipal Science & Technology Commission, 2008. 2. Clinical Research Award, Cancer Hospital, Chinese Academy of Medical Sciences, 2006. 3. Clinical Research Award, Beijing Anti-cancer Society, 2001. 4. Clinical Research Fund Award, Cancer Hospital (Institute), Chinese Academy of Medical Sciences, 2004. 5. Clinical Research Award, Cancer Hospital, Chinese Academy of Medical Sciences, 2003. 6. Clinical Research Award, Cancer Hospital, Chinese Academy of Medical Sciences, 2002. 7. Clinical Research Award, Cancer Hospital, Chinese Academy of Medical Sciences, 2001. Publications (First Author£¬Selected) 1. Dai H, Hui Z, Ji W, et al. Postoperative radiotherapy for resected pathological stage ¢óA-N2 non-small-cell lung cancer: A retrospective study of 221 cases from a single institution. Oncologist. 2011;16(5):641-650. 2. Hui Z, Tretiakova M, Zhang Z,et al. Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):288-295. 3. Hui Z, Zhang X, Starkschall G, et al. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1385-1395. 4. Hui Z, Li Y, Yu Z, et al. Survey on use of postmastectomy radiotherapy for breast cancer in China. Int J Radiat Oncol Bio phys, 66(4):1135-1142, 2006. 5. Hui Z, Gao L, Yi J, et al. Significcance of cranial nerve involvement shown by the prognosis of nasopharyngeal carcinoma. Chin J Radiat Oncol, 15:359-362, 2006. 6. Hui Z, Li YX, Yang WZ, Gao YH, Yu ZH. Radiosensitization mechanism of UCN-01 in nasopharyngeal cancer cell. Chin J Radiat Oncol, 15:46-49, 2006. 7. Hui Z, Li YX, Yang WZ, et al. Abrogation effect of UCN-01 on radiation-induced G2 phase arrest of tumor cells and its mechanism. Chin J Cancer, 24(1):1-6,2005. 8. Hui Z, Xu GZ. Clinical practice in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Chin J Pract Oncol, 19(2)104-106, 2004. 9. Hui Z, Yu ZH. How to design the prospective stage I/II dose escalation trial on radiotherapy. Chin J Radiat Oncol,13(3):233-237,2004. 10. Hui Z, Xiao JP, Xu GZ. Radiotherapy for chemodectoma: a case report and review. Chin J Neuro-Oncol, 2(2):118-120,2004. 11. Hui Z, Li YX, Yang WZ, Wu JX, Yu ZH. Abrogation of radiation-induced G2 arrest and radiosensitization by staurosporine in human nasopharyngeal carcinoma cell line. Chin J Cancer, 22:6-10, 2003. 12. Hui Z, Yu ZH, Xu GZ. Effect of epidermal growth factor receptor on radiotherapy. Chin J Radiat Oncol, 12:85-88, 2003. 13. Hui Z, Yin WB. A major advance in radiotherapy: Intensity-modulated radiotherapy. Progress Clin Oncol, 1(1):14-19,2003. 14. Hui Z, Li YX, Yang WZ, Wu JX, Yu ZH. Potentiation of radiosensitivity by 7-hydroxystaurosporine (UCN-01) in a pulmonary adenocarcinoma cell line. Chin J Chin J Radiat Oncol, 11:255-258, 2003. 15. Hui ZG, Yu ZH. Radiotherapy for early breast cancer. Chin J Pract Oncol, 17:370-372, 2002. 16. Hui ZG, Wang LH, Yin WB. Preoperative concurrent chemoradiotherapy for esophageal carcinoma. Chin J Radiat Oncol, 11:212-215, 2002. 17. Hui ZG, Yu ZH. Dose escalation study of carmofur in the postoperative chemoradiotherapy of rectal cancer. Chin J cancer prevention & Treat, 8:292-294, 2001. 18. Hui ZG, Xu GZ. Intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int Med Devices, 87:18-20, 2002. 19. Hui ZG, Li YX, Wu JX, Yu ZH. The effect of the extent of dissecting and detecting axillary node on postoperative radiotherapy in breast cancer Chin J Radiat Oncol, 10:148-152, 2001. 20. Hui ZG, Yu ZH. Clinical significance of the number of dissected and detected axillary lymphnode in early breast cancer. Foreign Medical Sciences, Cancer Section,28:217-220,2001 21. Hui ZG, Yu ZH. Radiotherapy for early breast cancer after radical or modified radical mastectomy. Chin J Radiat Oncol, 10:62-64, 2001. Book Chapters 1. Hui ZG, Xu B: Molecular biology of radiation biology. In Yin WB, Yu ZH, Xu GZ, Hu YM, eds: Radiation Oncology, Peking Union Medical Collogy Press, 2008, pp292-306. 2. Hui ZG, Xu XN: Breast cancer. In Zhu GY, eds: Radiation Oncology, Sciences and Techniques Press, 2006, pp447-464. 3. Hui ZG, Xu GZ: Intensity-modulated radiotherapy for nasopharyngeal carcinoma. In Shen WJ, Wang LH, Xia TY, eds: New Techniques of Radiation Oncology, Beijing Sciences and Techniques Press, 2003, pp44-60. 4. Hui ZG, Yu ZH: How to design the prospective stage I/II dose escalation trial on radiotherapy. In Shen WJ, Wang LH, Xia TY, eds: New Techniques of Radiation Oncology, Beijing Sciences and Techniques Press, 2003, pp294-300. Abstracts Accepted or Meetings Attended 1. Hui Z, Dai H, Liang J, et al. Selection of proper candidates with resected ¢óA-N2 non-small-cell lung cancer for postoperative radiotherapy: A new prediction model. The 53st Annual Meeting of the American Society for Radiation Oncology£¬2011. Miami, USA. Poster Discussion. 2. Hui Z, Xiao Z, Zhou Z, et al. Target Determination of Postoperative Radiotherapy for Thoracic Esophageal Carcinoma Based on the Data of a Prospective Randomized Trial. The 51st Annual Meeting of the American Society for Radiation Oncology£¬2009. Chicago, USA. Poster. 3. Hui Z, Wang X, Zhang ZF, et al. Gene expression profiling after irradiation in radio-resistant human renal cell carcinoma (RCC). The 94th Annual Meeting of the Radiological Society of North America, 2008. Chicago, USA. oral presentation. 4. Hui Z, Zhang X, Chang J, et al. Effects of inter-fraction anatomic changes on proton therapy dose distributions in lung cancer. The 39th Annual Meeting of the American Society fir Radiation Oncology£¬2007. Los Angeles, USA. Poster discussion. 5. Hui Z, Betten M, Huang D, et al. STAT1 is over-expressed in clear cell renal cell carcinoma (RCC): radioresistance and clinical implications. The 38th Annual Meeting of the American Society for Radiation Oncology£¬2006. Philadelphia, USA. Poster. 6. IAEA/RCA Regional Training Course on 3D Conformal Radiotherapy and QA ¨C Part I £¨for Radiation Oncologists£©. 23-27 April 2008. Bangkok, Thailand. 7. MDACC Radone 2006, 2006.02£¬ Houston, USA 8. Stereotactic Body Radiation Therapy: Clinical, Technical and Translational Aspects, 2006.05, Dallas, USA 9. The 38th Annual Meeting of the American Society for Radiation Oncology£¬2005.10£¬ Denver, USA
Contact the presenter at: drhuizg@163.com

Abstract:


E-mail a friend about this poster:
Enter email address: